Bovie Medical Corporation EV/EBIT

EV/EBIT of APYX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBIT growth rates and interactive chart. EV/EBIT is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes (EBIT), but after Depreciation and Amortization.. The EV/EBIT ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBIT compared to a stock’s historical average or industry can indicate undervaluation. EV/EBIT takes into account the reinvestment needs of a business (depreciation, amortization).


Highlights and Quick Summary

Current EV/EBIT of Bovie Medical Corporation is 0.0 (as of December 30, 2019)
  • EV/EBIT for the quarter ending June 29, 2020 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBIT decreased by NaN%
  • Annual EV/EBIT for 2019 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2018 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2017 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/APYX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBIT of Bovie Medical Corporation

Most recent EV/EBITof APYX including historical data for past 10 years.

Interactive Chart of EV/EBIT of Bovie Medical Corporation

Bovie Medical Corporation EV/EBIT for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0 0.0
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 0.0 0.0
2014 0.0 0.0 0.0 0.0 0.0
2013 0.0 0.0 0.0 0.0 0.0
2012 0.0 0.0 0.0 0.0 0.0
2011 0.0 0.0 0.0 0.0 0.0
2010 0.0 0.0 0.0 0.0 0.0
2009 0.0 0.0

Business Profile of Bovie Medical Corporation

Sector: Medical
Industry: Med Prods
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.